Literature DB >> 23897242

Trends in the epidemiology of pediatric severe sepsis*.

Mary E Hartman1, Walter T Linde-Zwirble, Derek C Angus, R Scott Watson.   

Abstract

OBJECTIVES: In the past decade, guidelines have been developed for the early detection and management of severe sepsis in children and neonates. However, severe sepsis continues to be a significant U.S. healthcare problem, accounting for over 720,000 annual hospitalizations. Large-scale epidemiologic studies of severe sepsis continue to be limited, particularly in children. We present data from 1995, 2000, and 2005 in seven U.S. states, examining how case mix, outcome, and resource use for pediatric severe sepsis have changed over time.
DESIGN: We constructed a database including all acute-care hospitalizations for children in the seven states. For each case, we extracted data on demographic characteristics; the principal diagnosis, up to six secondary diagnoses, and six procedures as classified by the International Classification of Diseases, 9th Revision, Clinical Modification codes; and in-hospital fatality. We identified patients with severe sepsis using International Classification of Diseases, 9th Revision, Clinical Modification codes for both infection and acute organ failure.
SETTING: Retrospective observational cohort dataset from seven U.S. states from 1995, 2000, and 2005.
SUBJECTS: Children in the U.S. 0-19 years old.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: In 2005, 17,542 children were hospitalized with severe sepsis in the seven states; there was an 81% increase in pediatric severe sepsis cases since 1995 and a 45% increase since 2000. This corresponded to an increase in prevalence from 0.56 to 0.89 cases per 1,000 pediatric population. Between 1995 and 2005, the prevalence of severe sepsis in newborns more than doubled, from 4.5 to 9.7 cases per 1,000 births. The most common infecting organisms in all 3 years were Staphylococcus species. From 1995 to 2005, the case-fatality rate decreased from 10.3% to 8.9%. Case fatality associated with Staphylococcus aureus increased, whereas fatality associated with Streptococcus pneumoniae decreased by 75%. Nationally, there were 75,255 pediatric hospitalizations in 2005 involving severe sepsis, with an associated cost of $4.8 billion.
CONCLUSIONS: Between 1995 and 2005, the prevalence of severe sepsis in U.S. children steadily rose, due to a significant increase in the prevalence of severe sepsis in newborns.

Entities:  

Mesh:

Year:  2013        PMID: 23897242     DOI: 10.1097/PCC.0b013e3182917fad

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  171 in total

1.  Disseminated Intravascular Coagulation Is an Independent Predictor of Adverse Outcomes in Children in the Emergency Department with Suspected Sepsis.

Authors:  Leonora R Slatnick; Dianne Thornhill; Sara J Deakyne Davies; James B Ford; Halden F Scott; Marilyn J Manco-Johnson; Beth Boulden Warren
Journal:  J Pediatr       Date:  2020-06-14       Impact factor: 4.406

2.  Comparison of Methods for Identification of Pediatric Severe Sepsis and Septic Shock in the Virtual Pediatric Systems Database.

Authors:  Robert B Lindell; Akira Nishisaki; Scott L Weiss; Fran Balamuth; Danielle M Traynor; Marianne R Chilutti; Robert W Grundmeier; Julie C Fitzgerald
Journal:  Crit Care Med       Date:  2019-02       Impact factor: 7.598

3.  Emerging Biomarkers of Illness Severity: Urinary Metabolites Associated with Sepsis and Necrotizing Methicillin-Resistant Staphylococcus aureus Pneumonia.

Authors:  Lilliam Ambroggio; Todd A Florin; Samir S Shah; Richard Ruddy; Larisa Yeomans; Julie Trexel; Kathleen A Stringer
Journal:  Pharmacotherapy       Date:  2017-07-28       Impact factor: 4.705

Review 4.  Utility of Procalcitonin as a Biomarker for Sepsis in Children.

Authors:  Kevin J Downes; Julie C Fitzgerald; Scott L Weiss
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

Review 5.  Metabolomics as a Driver in Advancing Precision Medicine in Sepsis.

Authors:  Michelle Eckerle; Lilliam Ambroggio; Michael A Puskarich; Brent Winston; Alan E Jones; Theodore J Standiford; Kathleen A Stringer
Journal:  Pharmacotherapy       Date:  2017-07-31       Impact factor: 4.705

6.  The Legacy of Pediatric Sepsis State Legislation.

Authors:  Halden F Scott; Fran Balamuth; Elizabeth R Alpern
Journal:  Pediatrics       Date:  2020-07       Impact factor: 7.124

7.  Pediatric Outcomes After Regulatory Mandates for Sepsis Care.

Authors:  Kristin H Gigli; Billie S Davis; Jonathan G Yabes; Chung-Chou H Chang; Derek C Angus; Tina Batra Hershey; Jennifer R Marin; Grant R Martsolf; Jeremy M Kahn
Journal:  Pediatrics       Date:  2020-07       Impact factor: 7.124

Review 8.  The Economic and Humanistic Burden of Severe Sepsis.

Authors:  Bogdan Tiru; Ernest K DiNino; Abigail Orenstein; Patrick T Mailloux; Adam Pesaturo; Abhinav Gupta; William T McGee
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

Review 9.  Gene Expression Profiles in Children With Suspected Sepsis.

Authors:  Fran Balamuth; Elizabeth R Alpern; Mengyuan Kan; Maya Shumyatcher; Katie Hayes; Ebbing Lautenbach; Blanca E Himes
Journal:  Ann Emerg Med       Date:  2020-01-23       Impact factor: 5.721

10.  Activation of α2 adrenoceptor attenuates lipopolysaccharide-induced hepatic injury.

Authors:  Jing-Hui Chen; Gao-Feng Yu; Shang-Yi Jin; Wen-Hua Zhang; Dong-Xu Lei; Shao-Li Zhou; Xing-Rong Song
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.